ALPS
AlpsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ALPS
Alps Group Inc
A biotechnology research and development enterprise focused on precision and preventive medicine, creating a platform that integrates biotechnology research, medical services, and health solutions
Life Science Tools and Services
05/14/2024
10/31/2025
NASDAQ Stock Exchange
2
12-31
Common stock
Unit E-18-01 & E-18-02, Level 18, Icon Tower (East), No. 1, Jalan 1/68F, Jalan Tun Razak, 50400 Kuala Lumpur, Wilayah Persekutuan, Malaysia
--
Alps Group Inc is an exempted company with limited liability incorporated in the Cayman Islands on May 14, 2024. Alps' main goal is to develop into a fully integrated bench-to-bedside platform encompassing biotechnology research, medical services and health solutions. Alps' main activity is the research and development of various biotechnology-related products and services, with a focus on the use of precision and preventive medicine.
Company Financials
EPS
ALPS has released its 2022 Q2 earnings. EPS was reported at 0, versus the expected 0, meeting expectations. The chart below visualizes how ALPS has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
